Niggling the back of my brain is the recurring thought that big pharma won’t like MSB getting their market share.
Once Stem cell gets first accepted, an avalanche of alternative treatments will follow. Big pharma will be very reluctant to let this happen and will do whatever to prevent MSB getting its footprint through FDA.
How will they prevent this, ive no idea. However, you can bet it has been discussed.
So , either they buy into it if they hear about it as a serious threat or T/O. ????
Thoughts?
Ann: MSB Files GvHD Clinical Efficacy and Safety Data with US FDA, page-44
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.050(4.65%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.13 | $1.07 | $5.964M | 5.444M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 176236 | 7 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
0.050 ( 4.69 %) |
||||
| Open | High | Low | Volume | ||
| $1.09 | $1.13 | $1.07 | 829227 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| MSB (ASX) Chart |